Scaffolds from Self-Assembling Tetrapeptides Support 3D Spreading, Osteogenic Differentiation, and Angiogenesis of Mesenchymal Stem Cells.
Salwa AlshehriHepi H SusaptoCharlotte A E HauserPublished in: Biomacromolecules (2021)
The apparent rise of bone disorders demands advanced treatment protocols involving tissue engineering. Here, we describe self-assembling tetrapeptide scaffolds for the growth and osteogenic differentiation of human mesenchymal stem cells (hMSCs). The rationally designed peptides are synthetic amphiphilic self-assembling peptides composed of four amino acids that are nontoxic. These tetrapeptides can quickly solidify to nanofibrous hydrogels that resemble the extracellular matrix and provide a three-dimensional (3D) environment for cells with suitable mechanical properties. Furthermore, we can easily tune the stiffness of these peptide hydrogels by just increasing the peptide concentration, thus providing a wide range of peptide hydrogels with different stiffnesses for 3D cell culture applications. Since successful bone regeneration requires both osteogenesis and vascularization, our scaffold was found to be able to promote angiogenesis of human umbilical vein endothelial cells (HUVECs) in vitro. The results presented suggest that ultrashort peptide hydrogels are promising candidates for applications in bone tissue engineering.
Keyphrases
- tissue engineering
- endothelial cells
- mesenchymal stem cells
- bone regeneration
- extracellular matrix
- amino acid
- umbilical cord
- bone marrow
- high glucose
- vascular endothelial growth factor
- induced apoptosis
- bone mineral density
- magnetic resonance imaging
- cell cycle arrest
- cell therapy
- stem cells
- cell proliferation
- signaling pathway
- magnetic resonance
- cell death
- body composition